T1	AdverseReaction 179 203	Cardiovascular disorders
T2	AdverseReaction 215 237	venous thromboembolism
T3	AdverseReaction 239 257	pulmonary embolism
T4	AdverseReaction 259 265	stroke
T5	AdverseReaction 271 298	retinal vascular thrombosis
T6	AdverseReaction 322 341	Malignant neoplasms
T7	AdverseReaction 353 371	endometrial cancer
T8	AdverseReaction 373 386	breast cancer
T9	AdverseReaction 392 406	ovarian cancer
T10	AdverseReaction 453 472	gallbladder disease
T11	Factor 445 449	risk
T13	AdverseReaction 1174 1177	VTE
T14	Factor 1166 1170	risk
T15	AdverseReaction 1204 1210	stroke
T16	AdverseReaction 1215 1218	DVT
T18	DrugClass 1242 1250	estrogen
T19	AdverseReaction 1740 1746	stroke
T21	DrugClass 1807 1827	conjugated estrogens
T22	AdverseReaction 2127 2133	stroke
T23	Negation 2106 2108	no
T24	DrugClass 2160 2180	conjugated estrogens
T25	AdverseReaction 2480 2502	coronary heart disease
T26	AdverseReaction 2504 2507	CHD
T28	DrugClass 2636 2644	estrogen
T29	AdverseReaction 2537 2558	myocardial infarction
T30	AdverseReaction 2560 2588	silent myocardial infarction
T31	AdverseReaction 2593 2602	CHD death
T32	AdverseReaction 2813 2816	CHD
T33	Negation 2800 2809	reduction
T34	AdverseReaction 3043 3046	VTE
T35	AdverseReaction 3048 3051	DVT
T36	AdverseReaction 3056 3074	pulmonary embolism
T37	AdverseReaction 3076 3078	PE
T38	DrugClass 3121 3141	conjugated estrogens
T40	AdverseReaction 3254 3257	DVT
T42	AdverseReaction 3346 3349	VTE
T43	Factor 3350 3354	risk
T44	AdverseReaction 4147 4165	endometrial cancer
T46	DrugClass 4210 4218	estrogen
T47	AdverseReaction 4264 4282	endometrial cancer
T49	DrugClass 4304 4312	estrogen
T50	AdverseReaction 5798 5820	invasive breast cancer
T52	DrugClass 5716 5735	conjugated estrogen
T53	AdverseReaction 6478 6492	ovarian cancer
T55	DrugClass 6373 6381	estrogen
T56	AdverseReaction 7074 7082	dementia
T58	DrugClass 6990 6998	estrogen
T59	AdverseReaction 7114 7122	dementia
T61	DrugClass 7127 7129	CE
T64	AdverseReaction 7218 7226	dementia
T66	DrugClass 7231 7233	CE
T67	AdverseReaction 7452 7471	gallbladder disease
T68	Factor 7444 7448	risk
T70	AdverseReaction 7590 7617	Retinal vascular thrombosis
T72	AdverseReaction 8045 8072	increases in blood pressure
T73	Severity 8033 8044	substantial
T75	AdverseReaction 8394 8428	elevations of plasma triglycerides
T76	AdverseReaction 8440 8452	pancreatitis
T77	Factor 8371 8374	may
T79	AdverseReaction 9370 9404;9411 9417	increased thyroid-binding globulin levels
T80	AdverseReaction 9370 9379;9406 9409;9411 9417	increased TBG levels
T82	AdverseReaction 9477 9490	increased TBG
T83	AdverseReaction 9955 9970	fluid retention
T84	Factor 9930 9933	may
T89	AdverseReaction 10495 10505;10518 10528	exacerbate angioedema
T90	Factor 10491 10494	may
T101	AdverseReaction 11740 11774	Increased thyroid-binding globulin
T102	AdverseReaction 11740 11749;11776 11779	Increased TBG
T103	AdverseReaction 11792 11835	increased circulating total thyroid hormone
T104	AdverseReaction 12775 12801	Impaired glucose tolerance
T105	AdverseReaction 11960 11975;11979 11988	T3 resin uptake decreased
T106	AdverseReaction 12185 12193;12217 12248	elevated corticosteroid binding globulin
T107	AdverseReaction 12185 12193;12250 12253	elevated CBG
T108	AdverseReaction 12185 12193;12256 12284	elevated sex hormone-binding globulin
T109	AdverseReaction 12185 12193;12286 12290	elevated SHBG
T110	AdverseReaction 12304 12347	increased total circulating corticosteroids
T111	AdverseReaction 12304 12331;12352 12364	increased total circulating sex steroids
T112	Factor 12178 12181	may
T113	AdverseReaction 11282 11310	Accelerated prothrombin time
T114	AdverseReaction 11372 11396	increased platelet count
T115	AdverseReaction 11398 11418	increased factors II
T116	AdverseReaction 11398 11415;11420 11431	increased factors VII antigen
T117	AdverseReaction 11398 11415;11433 11445	increased factors VIII antigen
T118	AdverseReaction 11398 11415;11447 11470	increased factors VIII coagulant activity
T119	AdverseReaction 11398 11415;11472 11474	increased factors IX
T120	AdverseReaction 11398 11415;11476 11477	increased factors X
T121	AdverseReaction 11398 11415;11479 11482	increased factors XII
T122	AdverseReaction 11398 11415;11484 11497	increased factors VII-X complex
T123	AdverseReaction 11398 11415;11499 11515	increased factors II-VII-X complex
T124	AdverseReaction 11398 11407;11521 11541	increased beta-thromboglobulin
T125	AdverseReaction 11543 11576	decreased levels of antifactor Xa
T126	AdverseReaction 11543 11562;11581 11597	decreased levels of antithrombin III
T127	AdverseReaction 11599 11634	decreased antithrombin III activity
T128	AdverseReaction 11636 11666	increased levels of fibrinogen
T129	AdverseReaction 11636 11655;11671 11690	increased levels of fibrinogen activity
T130	AdverseReaction 11692 11721	increased plasminogen antigen
T131	AdverseReaction 11692 11713;11726 11734	increased plasminogen activity
T132	AdverseReaction 12005 12017	elevated TBG
T133	AdverseReaction 12380 12407;12452 12461	Free hormone concentrations decreased
T134	Factor 12445 12448	may
T135	AdverseReaction 12417 12429;12452 12461	testosterone decreased
T136	AdverseReaction 12434 12443;12452 12461	estradiol decreased
T137	AdverseReaction 12469 12484;12492 12501	plasma proteins increased
T138	AdverseReaction 12492 12501;12503 12518	increased angiotensinogen
T139	AdverseReaction 12492 12501;12519 12534	increased renin substrate
T140	AdverseReaction 12492 12501;12536 12555	increased alpha-1-antitrypsin
T141	AdverseReaction 12492 12501;12557 12570	increased ceruloplasmin
T142	Factor 12485 12488	may
T143	AdverseReaction 12577 12618	Increased plasma high-density lipoprotein
T145	AdverseReaction 12577 12586;12629 12672	Increased HDL2 cholesterol subfraction concentrations
T146	AdverseReaction 12674 12705;12712 12738	reduced low-density lipoprotein cholesterol concentrations
T147	AdverseReaction 12674 12681;12707 12710;12712 12738	reduced LDL cholesterol concentrations
T148	AdverseReaction 12740 12769	increased triglyceride levels
T27	AdverseReaction 8208 8214;8228 8245	effect on blood pressure
T51	Negation 8250 8253	not
T69	AdverseReaction 11282 11293;11312 11339	Accelerated partial thromboplastin time
T71	AdverseReaction 11282 11293;11345 11370	Accelerated platelet aggregation time
T74	AdverseReaction 11792 11801;11880 11889	increased T4 levels
T78	AdverseReaction 11792 11801;11929 11938	increased T3 levels
T81	AdverseReaction 12577 12586;12620 12623	Increased HDL
T86	Severity 2528 2536	nonfatal
E1	AdverseReaction:T1
E2	AdverseReaction:T2
E3	AdverseReaction:T3
E4	AdverseReaction:T4
E5	AdverseReaction:T5
E6	AdverseReaction:T6
E7	AdverseReaction:T7
E8	AdverseReaction:T8
E9	AdverseReaction:T9
E10	AdverseReaction:T10 Hypothetical:E11
E11	Factor:T11
E13	AdverseReaction:T13 Hypothetical:E14
E14	Factor:T14
E15	AdverseReaction:T15 Hypothetical2:E18
E16	AdverseReaction:T16 Hypothetical2:E18
E18	DrugClass:T18
E19	AdverseReaction:T19 Hypothetical2:E21
E21	DrugClass:T21
E22	AdverseReaction:T22 Negated:E23 Hypothetical:E24
E23	Negation:T23
E24	DrugClass:T24
E25	AdverseReaction:T25 Hypothetical:E28
E26	AdverseReaction:T26 Hypothetical:E28
E28	DrugClass:T28
E29	AdverseReaction:T29 Hypothetical:E28 Effect:E86
E30	AdverseReaction:T30 Hypothetical:E28
E31	AdverseReaction:T31 Hypothetical:E28
E32	AdverseReaction:T32 Negated:E33
E33	Negation:T33
E34	AdverseReaction:T34 Hypothetical2:E38
E35	AdverseReaction:T35 Hypothetical2:E38
E36	AdverseReaction:T36 Hypothetical2:E38
E37	AdverseReaction:T37 Hypothetical2:E38
E38	DrugClass:T38
E40	AdverseReaction:T40 Hypothetical2:E38
E42	AdverseReaction:T42 Hypothetical:E43
E43	Factor:T43
E44	AdverseReaction:T44 Hypothetical2:E46
E46	DrugClass:T46
E47	AdverseReaction:T47 Hypothetical:E49
E49	DrugClass:T49
E50	AdverseReaction:T50 Hypothetical:E52
E52	DrugClass:T52
E53	AdverseReaction:T53 Hypothetical2:E55
E55	DrugClass:T55
E56	AdverseReaction:T56 Hypothetical2:E58
E58	DrugClass:T58
E59	AdverseReaction:T59 Hypothetical2:E61
E61	DrugClass:T61
E64	AdverseReaction:T64 Hypothetical3:E66
E66	DrugClass:T66
E67	AdverseReaction:T67 Hypothetical:E68
E68	Factor:T68
E70	AdverseReaction:T70
E72	AdverseReaction:T72 Effect:E73
E73	Severity:T73
E75	AdverseReaction:T75 Hypothetical:E77
E76	AdverseReaction:T76 Hypothetical:E77
E77	Factor:T77
E79	AdverseReaction:T79
E80	AdverseReaction:T80
E82	AdverseReaction:T82
E83	AdverseReaction:T83 Hypothetical:E84
E84	Factor:T84
E89	AdverseReaction:T89 Hypothetical:E90
E90	Factor:T90
E101	AdverseReaction:T101
E102	AdverseReaction:T102
E103	AdverseReaction:T103
E104	AdverseReaction:T104
E105	AdverseReaction:T105
E106	AdverseReaction:T106 Hypothetical:E112
E107	AdverseReaction:T107 Hypothetical:E112
E108	AdverseReaction:T108 Hypothetical:E112
E109	AdverseReaction:T109 Hypothetical:E112
E110	AdverseReaction:T110 Hypothetical:E112
E111	AdverseReaction:T111 Hypothetical:E112
E112	Factor:T112
E113	AdverseReaction:T113
E114	AdverseReaction:T114
E115	AdverseReaction:T115
E116	AdverseReaction:T116
E117	AdverseReaction:T117
E118	AdverseReaction:T118
E119	AdverseReaction:T119
E120	AdverseReaction:T120
E121	AdverseReaction:T121
E122	AdverseReaction:T122
E123	AdverseReaction:T123
E124	AdverseReaction:T124
E125	AdverseReaction:T125
E126	AdverseReaction:T126
E127	AdverseReaction:T127
E128	AdverseReaction:T128
E129	AdverseReaction:T129
E130	AdverseReaction:T130
E131	AdverseReaction:T131
E132	AdverseReaction:T132
E133	AdverseReaction:T133 Hypothetical:E134
E134	Factor:T134
E135	AdverseReaction:T135 Hypothetical:E134
E136	AdverseReaction:T136 Hypothetical:E134
E137	AdverseReaction:T137 Hypothetical:E142
E138	AdverseReaction:T138 Hypothetical:E142
E139	AdverseReaction:T139 Hypothetical:E142
E140	AdverseReaction:T140 Hypothetical:E142
E141	AdverseReaction:T141 Hypothetical:E142
E142	Factor:T142
E143	AdverseReaction:T143
E145	AdverseReaction:T145
E146	AdverseReaction:T146
E147	AdverseReaction:T147
E148	AdverseReaction:T148
E27	AdverseReaction:T27 Negated:E51
E51	Negation:T51
E69	AdverseReaction:T69
E71	AdverseReaction:T71
E74	AdverseReaction:T74
E78	AdverseReaction:T78
E81	AdverseReaction:T81
E86	Severity:T86
A1	CUI E1 C0007222
A2	UMLS-Preferred-Name E1 Cardiovascular Diseases
A3	MEDDRA-PT E1 Cardiovascular disorder
A4	MEDDRA-PT-ID E1 10007649
A5	CUI E2 C1861172
A6	UMLS-Preferred-Name E2 Venous Thromboembolism
A7	MEDDRA-PT E2 Embolism venous
A8	MEDDRA-PT-ID E2 10014522
A9	LLT E2 Venous thromboembolism
A10	LLT-ID E2 10066899
A11	CUI E3 C0034065
A12	UMLS-Preferred-Name E3 Pulmonary Embolism
A13	MEDDRA-PT E3 Pulmonary embolism
A14	MEDDRA-PT-ID E3 10037377
A15	CUI E4 C0038454
A16	UMLS-Preferred-Name E4 Cerebrovascular accident
A17	MEDDRA-PT E4 Cerebrovascular accident
A18	MEDDRA-PT-ID E4 10008190
A19	LLT E4 Stroke
A20	LLT-ID E4 10042244
A21	CUI E5 C0919714
A22	UMLS-Preferred-Name E5 Retinal vascular thrombosis
A23	MEDDRA-PT E5 Retinal vascular thrombosis
A24	MEDDRA-PT-ID E5 10062108
A25	CUI E6 C0006826
A26	UMLS-Preferred-Name E6 Malignant Neoplasms
A27	MEDDRA-PT E6 Neoplasm malignant
A28	MEDDRA-PT-ID E6 10028997
A29	CUI E7 C0476089
A30	UMLS-Preferred-Name E7 Endometrial Carcinoma
A31	MEDDRA-PT E7 Endometrial cancer
A32	MEDDRA-PT-ID E7 10014733
A33	CUI E8 C0006142
A34	UMLS-Preferred-Name E8 Malignant neoplasm of breast
A35	MEDDRA-PT E8 Breast cancer
A36	MEDDRA-PT-ID E8 10006187
A37	CUI E9 C1140680
A38	UMLS-Preferred-Name E9 Malignant neoplasm of ovary
A39	MEDDRA-PT E9 Ovarian cancer
A40	MEDDRA-PT-ID E9 10033128
A41	CUI E10 C0016977
A42	UMLS-Preferred-Name E10 Gall Bladder Diseases
A43	MEDDRA-PT E10 Gallbladder disorder
A44	MEDDRA-PT-ID E10 10017626
A45	LLT E10 Gallbladder disease
A46	LLT-ID E10 10017641
A47	CUI E13 C1861172
A48	UMLS-Preferred-Name E13 Venous Thromboembolism
A49	MEDDRA-PT E13 Embolism venous
A50	MEDDRA-PT-ID E13 10014522
A51	LLT E13 Venous thromboembolism
A52	LLT-ID E13 10066899
A53	CUI E15 C0038454
A54	UMLS-Preferred-Name E15 Cerebrovascular accident
A55	MEDDRA-PT E15 Cerebrovascular accident
A56	MEDDRA-PT-ID E15 10008190
A57	LLT E15 Stroke
A58	LLT-ID E15 10042244
A59	CUI E16 C0149871
A60	UMLS-Preferred-Name E16 Deep Vein Thrombosis
A61	MEDDRA-PT E16 Deep vein thrombosis
A62	MEDDRA-PT-ID E16 10051055
A63	LLT E16 DVT
A64	LLT-ID E16 10013877
A65	CUI E19 C0038454
A66	UMLS-Preferred-Name E19 Cerebrovascular accident
A67	MEDDRA-PT E19 Cerebrovascular accident
A68	MEDDRA-PT-ID E19 10008190
A69	LLT E19 Stroke
A70	LLT-ID E19 10042244
A71	CUI E22 C0038454
A72	UMLS-Preferred-Name E22 Cerebrovascular accident
A73	MEDDRA-PT E22 Cerebrovascular accident
A74	MEDDRA-PT-ID E22 10008190
A75	LLT E22 Stroke
A76	LLT-ID E22 10042244
A77	CUI E25 C0010068
A78	UMLS-Preferred-Name E25 Coronary heart disease
A79	MEDDRA-PT E25 Coronary artery disease
A80	MEDDRA-PT-ID E25 10011078
A81	LLT E25 Coronary heart disease
A82	LLT-ID E25 10068617
A83	CUI E26 C0010068
A84	UMLS-Preferred-Name E26 Coronary heart disease
A85	MEDDRA-PT E26 Coronary artery disease
A86	MEDDRA-PT-ID E26 10011078
A87	LLT E26 Coronary heart disease
A88	LLT-ID E26 10068617
A89	CUI E29 C0027051
A90	UMLS-Preferred-Name E29 Myocardial Infarction
A91	MEDDRA-PT E29 Myocardial infarction
A92	MEDDRA-PT-ID E29 10028596
A93	CUI E30 C0340324
A94	UMLS-Preferred-Name E30 Silent myocardial infarction
A95	MEDDRA-PT E30 Silent myocardial infarction
A96	MEDDRA-PT-ID E30 10049768
A97	CUI E31 C0376297
A98	UMLS-Preferred-Name E31 Cardiac Death
A99	MEDDRA-PT E31 Cardiac death
A100	MEDDRA-PT-ID E31 10049993
A101	CUI E32 C0010068
A102	UMLS-Preferred-Name E32 Coronary heart disease
A103	MEDDRA-PT E32 Coronary artery disease
A104	MEDDRA-PT-ID E32 10011078
A105	LLT E32 Coronary heart disease
A106	LLT-ID E32 10068617
A107	CUI E34 C1861172
A108	UMLS-Preferred-Name E34 Venous Thromboembolism
A109	MEDDRA-PT E34 Embolism venous
A110	MEDDRA-PT-ID E34 10014522
A111	LLT E34 Venous thromboembolism
A112	LLT-ID E34 10066899
A113	CUI E35 C0149871
A114	UMLS-Preferred-Name E35 Deep Vein Thrombosis
A115	MEDDRA-PT E35 Deep vein thrombosis
A116	MEDDRA-PT-ID E35 10051055
A117	LLT E35 DVT
A118	LLT-ID E35 10013877
A119	CUI E36 C0034065
A120	UMLS-Preferred-Name E36 Pulmonary Embolism
A121	MEDDRA-PT E36 Pulmonary embolism
A122	MEDDRA-PT-ID E36 10037377
A123	CUI E37 C0034065
A124	UMLS-Preferred-Name E37 Pulmonary Embolism
A125	MEDDRA-PT E37 Pulmonary embolism
A126	MEDDRA-PT-ID E37 10037377
A127	CUI E40 C0149871
A128	UMLS-Preferred-Name E40 Deep Vein Thrombosis
A129	MEDDRA-PT E40 Deep vein thrombosis
A130	MEDDRA-PT-ID E40 10051055
A131	LLT E40 DVT
A132	LLT-ID E40 10013877
A133	CUI E42 C1861172
A134	UMLS-Preferred-Name E42 Venous Thromboembolism
A135	MEDDRA-PT E42 Embolism venous
A136	MEDDRA-PT-ID E42 10014522
A137	LLT E42 Venous thromboembolism
A138	LLT-ID E42 10066899
A139	CUI E44 C0476089
A140	UMLS-Preferred-Name E44 Endometrial Carcinoma
A141	MEDDRA-PT E44 Endometrial cancer
A142	MEDDRA-PT-ID E44 10014733
A143	CUI E47 C0476089
A144	UMLS-Preferred-Name E47 Endometrial Carcinoma
A145	MEDDRA-PT E47 Endometrial cancer
A146	MEDDRA-PT-ID E47 10014733
A147	CUI E50 C0853879
A148	UMLS-Preferred-Name E50 Invasive breast carcinoma
A149	MEDDRA-PT E50 Invasive breast carcinoma
A150	MEDDRA-PT-ID E50 10075713
A151	CUI E53 C1140680
A152	UMLS-Preferred-Name E53 Malignant neoplasm of ovary
A153	MEDDRA-PT E53 Ovarian cancer
A154	MEDDRA-PT-ID E53 10033128
A155	CUI E56 C0497327
A156	UMLS-Preferred-Name E56 Dementia
A157	MEDDRA-PT E56 Dementia
A158	MEDDRA-PT-ID E56 10012267
A159	CUI E59 C0497327
A160	UMLS-Preferred-Name E59 Dementia
A161	MEDDRA-PT E59 Dementia
A162	MEDDRA-PT-ID E59 10012267
A163	CUI E64 C0497327
A164	UMLS-Preferred-Name E64 Dementia
A165	MEDDRA-PT E64 Dementia
A166	MEDDRA-PT-ID E64 10012267
A167	CUI E67 C0016977
A168	UMLS-Preferred-Name E67 Gall Bladder Diseases
A169	MEDDRA-PT E67 Gallbladder disorder
A170	MEDDRA-PT-ID E67 10017626
A171	LLT E67 Gallbladder disease
A172	LLT-ID E67 10017641
A173	CUI E70 C0919714
A174	UMLS-Preferred-Name E70 Retinal vascular thrombosis
A175	MEDDRA-PT E70 Retinal vascular thrombosis
A176	MEDDRA-PT-ID E70 10062108
A177	CUI E72 C0497247
A178	UMLS-Preferred-Name E72 Increase in blood pressure
A179	MEDDRA-PT E72 Blood pressure increased
A180	MEDDRA-PT-ID E72 10005750
A181	CUI E75 C0858041
A182	UMLS-Preferred-Name E75 Plasma triglycerides increased
A183	MEDDRA-PT E75 Blood triglycerides increased
A184	MEDDRA-PT-ID E75 10005839
A185	LLT E75 Plasma triglycerides increased
A186	LLT-ID E75 10035456
A187	CUI E76 C0030305
A188	UMLS-Preferred-Name E76 Pancreatitis
A189	MEDDRA-PT E76 Pancreatitis
A190	MEDDRA-PT-ID E76 10033645
A191	CUI E79 C1168501
A192	UMLS-Preferred-Name E79 Thyroid hormone binding index increased
A193	MEDDRA-PT E79 Thyroxin binding globulin increased
A194	MEDDRA-PT-ID E79 10051420
A195	CUI E80 C0241400
A196	UMLS-Preferred-Name E80 Thyroxin binding globulin increased
A197	MEDDRA-PT E80 Thyroxin binding globulin increased
A198	MEDDRA-PT-ID E80 10051420
A199	CUI E82 C0241400
A200	UMLS-Preferred-Name E82 Thyroxin binding globulin increased
A201	MEDDRA-PT E82 Thyroxin binding globulin increased
A202	MEDDRA-PT-ID E82 10051420
A203	CUI E83 C0268000
A204	UMLS-Preferred-Name E83 Body fluid retention
A205	MEDDRA-PT E83 Fluid retention
A206	MEDDRA-PT-ID E83 10016807
A207	CUI E89 C0863128
A208	UMLS-Preferred-Name E89 Angioedema aggravated
A209	MEDDRA-PT E89 Angioedema
A210	MEDDRA-PT-ID E89 10002424
A211	LLT E89 Angioedema aggravated
A212	LLT-ID E89 10048331
A213	CUI E101 C0241400
A214	UMLS-Preferred-Name E101 Thyroxin binding globulin increased
A215	MEDDRA-PT E101 Thyroxin binding globulin increased
A216	MEDDRA-PT-ID E101 10051420
A217	CUI E102 C0241400
A218	UMLS-Preferred-Name E102 Thyroxin binding globulin increased
A219	MEDDRA-PT E102 Thyroxin binding globulin increased
A220	MEDDRA-PT-ID E102 10051420
A221	CUI E103 C1328578
A222	UMLS-Preferred-Name E103 Thyroid hormones increased
A223	MEDDRA-PT E103 Thyroid hormones increased
A224	MEDDRA-PT-ID E103 10063161
A225	CUI E104 C0159069
A226	UMLS-Preferred-Name E104 abnormal glucose tolerance test
A227	MEDDRA-PT E104 Glucose tolerance impaired
A228	MEDDRA-PT-ID E104 10018429
A229	CUI E105 C0241322
A230	UMLS-Preferred-Name E105 Tri-iodothyronine uptake decreased
A231	MEDDRA-PT E105 Tri-iodothyronine uptake decreased
A232	MEDDRA-PT-ID E105 10044601
A233	LLT E105 T3 uptake decreased
A234	LLT-ID E105 10043057
A235	CUI E106 C3544308
A236	UMLS-Preferred-Name E106 Corticosteroid binding globulin increased
A237	MEDDRA-PT E106 Corticosteroid binding globulin increased
A238	MEDDRA-PT-ID E106 10072935
A239	CUI E107 C3544308
A240	UMLS-Preferred-Name E107 Corticosteroid binding globulin increased
A241	MEDDRA-PT E107 Corticosteroid binding globulin increased
A242	MEDDRA-PT-ID E107 10072935
A243	CUI E108 C1167859
A244	UMLS-Preferred-Name E108 Sex hormone binding globulin increased
A245	MEDDRA-PT E108 Sex hormone binding globulin increased
A246	MEDDRA-PT-ID E108 10059659
A247	CUI E109 C1167859
A248	UMLS-Preferred-Name E109 Sex hormone binding globulin increased
A249	MEDDRA-PT E109 Sex hormone binding globulin increased
A250	MEDDRA-PT-ID E109 10059659
A251	CUI E110 C0001622
A252	UMLS-Preferred-Name E110 Adrenal Gland Hyperfunction
A253	MEDDRA-PT E110 Hypercorticoidism
A254	MEDDRA-PT-ID E110 10020610
A255	flag E111 duplicate
A256	CUI E111 C0241358
A257	UMLS-Preferred-Name E111 Increased testosterone
A258	MEDDRA-PT E111 Blood testosterone increased
A259	MEDDRA-PT-ID E111 10005815
A260	LLT E111 Testosterone increased
A261	LLT-ID E111 10043370
A262	CUI E113 C0580413
A263	UMLS-Preferred-Name E113 Prothrombin time low
A264	MEDDRA-PT E113 Prothrombin time shortened
A265	MEDDRA-PT-ID E113 10037070
A266	CUI E114 C0857460
A267	UMLS-Preferred-Name E114 Increased number of platelets
A268	MEDDRA-PT E114 Platelet count increased
A269	MEDDRA-PT-ID E114 10051608
A270	CUI E115 C0151872
A271	UMLS-Preferred-Name E115 Prothrombin time increased
A272	MEDDRA-PT E115 Prothrombin level increased
A273	MEDDRA-PT-ID E115 10037051
A274	LLT E115 Coagulation factor II level increased
A275	LLT-ID E115 10009741
A276	flag E116 unmapped
A277	flag E117 unmapped
A278	CUI E118 C0855412
A279	UMLS-Preferred-Name E118 Coagulation factor VIII level increased
A280	MEDDRA-PT E118 Coagulation factor VIII level increased
A281	MEDDRA-PT-ID E118 10009770
A282	CUI E119 C0855396
A283	UMLS-Preferred-Name E119 Coagulation factor IX level increased
A284	MEDDRA-PT E119 Coagulation factor IX level increased
A285	MEDDRA-PT-ID E119 10009748
A286	CUI E120 C0855416
A287	UMLS-Preferred-Name E120 Coagulation factor X level increased
A288	MEDDRA-PT E120 Coagulation factor X level increased
A289	MEDDRA-PT-ID E120 10009776
A290	CUI E121 C0855424
A291	UMLS-Preferred-Name E121 Coagulation factor XII level increased
A292	MEDDRA-PT E121 Coagulation factor XII level increased
A293	MEDDRA-PT-ID E121 10009784
A294	flag E122 unmapped
A295	flag E123 unmapped
A296	flag E124 unmapped
A297	flag E125 unmapped
A298	CUI E126 C0238665
A299	UMLS-Preferred-Name E126 Antithrombin III decreased
A300	MEDDRA-PT E126 Antithrombin III decreased
A301	MEDDRA-PT-ID E126 10049547
A302	CUI E127 C3670602
A303	UMLS-Preferred-Name E127 Antithrombin III activity decreased below normal range
A304	MEDDRA-PT E127 Antithrombin III decreased
A305	MEDDRA-PT-ID E127 10049547
A306	CUI E128 C0852921
A307	UMLS-Preferred-Name E128 Blood fibrinogen increased
A308	MEDDRA-PT E128 Blood fibrinogen increased
A309	MEDDRA-PT-ID E128 10005521
A310	LLT E128 Fibrinogen increased
A311	LLT-ID E128 10016597
A312	CUI E129 C0852921
A313	UMLS-Preferred-Name E129 Blood fibrinogen increased
A314	MEDDRA-PT E129 Blood fibrinogen increased
A315	MEDDRA-PT-ID E129 10005521
A316	LLT E129 Fibrinogen increased
A317	LLT-ID E129 10016597
A318	CUI E130 C1167843
A319	UMLS-Preferred-Name E130 Plasminogen activator inhibitor increased
A320	MEDDRA-PT E130 Plasminogen activator inhibitor increased
A321	MEDDRA-PT-ID E130 10059618
A322	CUI E131 C0855434
A323	UMLS-Preferred-Name E131 Plasminogen increased
A324	MEDDRA-PT E131 Plasminogen increased
A325	MEDDRA-PT-ID E131 10035495
A326	CUI E132 C0241400
A327	UMLS-Preferred-Name E132 Thyroxin binding globulin increased
A328	MEDDRA-PT E132 Thyroxin binding globulin increased
A329	MEDDRA-PT-ID E132 10051420
A330	flag E133 unmapped
A331	CUI E135 C1295654
A332	UMLS-Preferred-Name E135 Decreased testosterone level
A333	MEDDRA-PT E135 Blood testosterone decreased
A334	MEDDRA-PT-ID E135 10005814
A335	LLT E135 Testosterone decreased
A336	LLT-ID E135 10043368
A337	CUI E136 C0860850
A338	UMLS-Preferred-Name E136 Oestradiol decreased
A339	MEDDRA-PT E136 Oestradiol decreased
A340	MEDDRA-PT-ID E136 10030229
A341	LLT E136 Estradiol decreased
A342	LLT-ID E136 10054509
A343	CUI E137 C0855758
A344	UMLS-Preferred-Name E137 Protein total increased
A345	MEDDRA-PT E137 Protein total increased
A346	MEDDRA-PT-ID E137 10037016
A347	flag E138 unmapped
A348	flag E139 unmapped
A349	CUI E140 C0860914
A350	UMLS-Preferred-Name E140 Alpha-1 anti-trypsin increased
A351	MEDDRA-PT E140 Alpha-1 anti-trypsin increased
A352	MEDDRA-PT-ID E140 10001808
A353	CUI E141 C0236043
A354	UMLS-Preferred-Name E141 Ceruloplasmin increased
A355	MEDDRA-PT E141 Ceruloplasmin increased
A356	MEDDRA-PT-ID E141 10008219
A357	CUI E143 C0853084
A358	UMLS-Preferred-Name E143 High density lipoprotein increased
A359	MEDDRA-PT E143 High density lipoprotein increased
A360	MEDDRA-PT-ID E143 10020061
A361	flag E145 underspecified
A362	CUI E145 C0853084
A363	UMLS-Preferred-Name E145 High density lipoprotein increased
A364	MEDDRA-PT E145 High density lipoprotein increased
A365	MEDDRA-PT-ID E145 10020061
A366	LLT E145 HDL cholesterol increased
A367	LLT-ID E145 10070544
A368	CUI E146 C0853085
A369	UMLS-Preferred-Name E146 Decreased LDL
A370	MEDDRA-PT E146 Low density lipoprotein decreased
A371	MEDDRA-PT-ID E146 10024909
A372	CUI E147 C0853085
A373	UMLS-Preferred-Name E147 Decreased LDL
A374	MEDDRA-PT E147 Low density lipoprotein decreased
A375	MEDDRA-PT-ID E147 10024909
A376	LLT E147 Decreased LDL
A377	LLT-ID E147 10011972
A378	CUI E148 C1522137
A379	UMLS-Preferred-Name E148 Hypertriglyceridemia result
A380	MEDDRA-PT E148 Blood triglycerides increased
A381	MEDDRA-PT-ID E148 10005839
A382	LLT E148 Triglycerides high
A383	LLT-ID E148 10052373
A384	CUI E27 C1268766
A385	UMLS-Preferred-Name E27 Blood pressure alteration (finding)
A386	MEDDRA-PT E27 Blood pressure fluctuation
A387	MEDDRA-PT-ID E27 10005746
A388	LLT E27 Change in blood pressure
A389	LLT-ID E27 10008393
A390	CUI E69 C0853224
A391	UMLS-Preferred-Name E69 Activated partial thromboplastin time shortened
A392	MEDDRA-PT E69 Activated partial thromboplastin time shortened
A393	MEDDRA-PT-ID E69 10000637
A394	LLT E69 Partial thromboplastin time shortened
A395	LLT-ID E69 10075335
A396	CUI E71 C2745924
A397	UMLS-Preferred-Name E71 Platelet aggregation increased (finding)
A398	MEDDRA-PT E71 Platelet aggregation increased
A399	MEDDRA-PT-ID E71 10035518
A400	CUI E74 C1295665
A401	UMLS-Preferred-Name E74 Increased thyroxine level
A402	MEDDRA-PT E74 Thyroxine increased
A403	MEDDRA-PT-ID E74 10043818
A404	LLT E74 T4 increased
A405	LLT-ID E74 10043063
A406	CUI E78 C1295668
A407	UMLS-Preferred-Name E78 Increased triiodothyronine level
A408	MEDDRA-PT E78 Tri-iodothyronine increased
A409	MEDDRA-PT-ID E78 10044596
A410	LLT E78 T3 increased
A411	LLT-ID E78 10043053
A412	CUI E81 C0853084
A413	UMLS-Preferred-Name E81 High density lipoprotein increased
A414	MEDDRA-PT E81 High density lipoprotein increased
A415	MEDDRA-PT-ID E81 10020061
A416	LLT E81 Increased HDL
A417	LLT-ID E81 10021662
